In a landmark development, Blue Cross Blue Shield (BCBS) has reached a $2.8 billion settlement to resolve antitrust claims brought by health care providers, including chiropractors. The lawsuit accused BCBS of dividing the nation into exclusive regions and limiting competition, which resulted in lower reimbursements for providers. Although BCBS denies any wrongdoing, the company agreed to the settlement to avoid lengthy litigation – and you can get a piece of the pie.
Manesh Girn, PhD
Dr. Manesh Girn is a postdoctoral neuroscientist specializing in psychedelic drugs at the University of California, San Francisco.Working closely with psychedelic research pioneer Dr. Robin Carhart-Harris, he conducts neuroimaging research on the neural mechanisms underlying the psychedelic experience and psychedelic-assisted psychotherapy in humans. He has been lead or co-author of over 20 peer-reviewed publications to date on topics including psychedelics, the default mode network, abstract cognitive processes, and brain network organization. Manesh also runs a popular digital platform on Instagram and YouTube called “The Psychedelic Scientist”; and serves as the chief research officer at EntheoTech Bioscience, a bioscience company focused on psychedelic-assisted psychotherapy and multidisciplinary mental health solutions. Find out more about Manesh and get in touch at www.maneshgirn.com.